Phey Liana

Phey Liana

Auto-generated profile, based on publicly available information

Phey Liana

Department of Clinical Pathology, Faculty of Medicine, Universitas Sriwijaya, Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2022 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
PLPhey Liana
Phey Liana
ILIche Andriyani Liberty
Iche Andriyani Liberty
KMKrisna - Murti
Krisna - Murti
ZHZen Hafy
Zen Hafy
ESEddy Mart Salim
Eddy Mart Salim
Tungki Pratama UmarTungki Pratama Umar
Tungki Pratama Umar

1 January 2022 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
FHFadhilatul Hilda
Fadhilatul Hilda
PLPhey Liana
Phey Liana
ANAwan Nurtjahyo
Awan Nurtjahyo
HHHarun Hudari
Harun Hudari
NSNurmalia Purnama Sari
Nurmalia Purnama Sari
AAAstari Rahayu Afifah
Astari Rahayu Afifah
Objective: The global case fatality rate of coronavirus disease 2019 is 2.16% as announced by the World Health Organization. In Indonesia, according to the Ministry of Health, the number is even higher, reaching a 2.8% case fatality rate. D-dimer levels were found to affect coronavirus disease 2019 patient’s survival in several studies. The study aimed to determine whether the amount of D-dimer predicted survival in coronavirus disease 2019 patients. Materials and Methods: This research was performed in a retrospective cohort design and used survival analysis. From March 1, 2020, to August 31, 2020, the samples were collected from polymerase chain reaction-confirmed coronavirus disease 2019 patients at Mohammad Hoesin General Hospital in Palembang, South Sumatera, Indonesia. We used electronic medical records to obtain demographic (age and gender), coexisting condition, laboratory (coagulation and hematologic test), and outcome (non-survivors or survivors) data. The chi-square and Mann–Whitney tests were used to evaluate the results. The Kaplan–Meier method and the Mantel–Haenszel log-rank test were used to examine D-dimer levels and patient outcomes. Youden index was calculated to determine the optimal cut-off value of D-dimer. Results: There were 52 non-survivors and 235 survivors among the 287 patients who met the inclusion criterion. Non-survivors had D-dimer levels of more than 1.49 mg/L in 82.69%of cases. Males had lower cut-off compared to females (>1.49 mg/L vs. >2.2 mg/L). The researchers discovered a highly significant correlation between D-dimer levels and coronavirus disease 2019 mortality (P=.001). The c-index analysis showed that D-dimer (0.79, 95% CI: 0.73-0.83) ability for mortality prediction was the second-best compared with other laboratory markers. Conclusion: D-dimer can be used as a predictor of coronavirus disease 2019 in-hospital mortality for early identification of coagulopathy Cite this article as: Hilda F, Liana P, Nurtjahyo A, et al. D-dimer as a sensitive biomarker of survival rate in patients with COVID-19. Eurasian J Med., 2022;54(3):219-224.

28 May 2024
Verified
Book Chapter
Open access
PDF file
Nityanand JainNityanand Jain
Nityanand Jain
Tungki Pratama UmarTungki Pratama Umar
Tungki Pratama Umar
Reem SayadReem Sayad
Reem Sayad
MMMuhammed Edib Mokresh
Muhammed Edib Mokresh
KTKevin Tandarto
Kevin Tandarto
ARAigars Reinis
Aigars Reinis
An outbreak of monkeypox (Mpox) was reported in more than 40 countries in early 2022. Accurate diagnosis of Mpox can be challenging, but history, clinical findings, and laboratory diagnosis can establish the diagnosis. The pre-analytic phase of testing includes collecting, storing, and transporting specimens. It is advised to swab the lesion site with virus transport medium (VTM) containing Dacron or polyester flock swabs from two different sites. Blood, urine, and semen samples may also be used. Timely sampling is necessary to obtain a sufficient amount of virus or antibodies. The analytical phase of infectious disease control involves diagnostic tools to determine the presence of the virus. While polymerase chain reaction (PCR) is the gold standard for detecting Mpox, genome sequencing is for identifying new or modified viruses. As a complement to these methods, isothermal amplification methods have been designed. ELISAassays are also available for the determination of antibodies. Electron microscopy is another effective diagnostic method for tissue identification of the virus. Wastewater fingerprinting provides some of the most effective diagnostic methods for virus identification at the community level. The advantages and disadvantages of these methods are further discussed. Post-analytic phase requires proper interpretation of test results and the preparation of accurate patient reports that include relevant medical history, clinical guidelines, and recommendations for follow-up testing or treatment.

23 June 2023 in PeerJ
Verified
Journal Article
Open access
PDF file
PLPhey Liana
Phey Liana
ASAprilia Paskah Samosir
Aprilia Paskah Samosir
NSNurmalia Purnama Sari
Nurmalia Purnama Sari
RARaden Ayu Linda Andriani
Raden Ayu Linda Andriani
VVVerdiansah Verdiansah
Verdiansah Verdiansah
Tungki Pratama UmarTungki Pratama Umar
Tungki Pratama Umar
Background: Coronavirus disease 2019 (COVID-19) is a contagious respiratory illness that was declared a pandemic in March 2020. Lymphopenia is one of the specific laboratory results disturbance in COVID-19 patients. Such findings are frequently associated with substantial changes in T-cell counts, particularly CD4+ and CD8+ T-cells. This study aimed to examine the correlation between CD4+ and CD8+ cell counts and absolute lymphocyte count (ALC) in COVID-19 patients and analyze its difference based on the COVID-19 patients’ severity. Methods: From March 2022 to May 2022, we conducted a retrospective cohort study using medical records and laboratory data from patients diagnosed with COVID-19 at our hospital who met the inclusion and exclusion criteria. The total sampling method was used to recruit study participants. We conducted bivariate analysis, which consisted of correlation and comparative analysis. Results: Thirty-five patients met the inclusion and exclusion criteria and were divided into two severity groups (mild-moderate and severe-critical). The findings of this study revealed a significant correlation between CD4+ cell count and ALC on admission (r = 0.69, p < 0.001) and the tenth day of onset (r = 0.559, p < 0.001). Similarly, there was a correlation between CD8+ and ALC at admission (r = 0.543, p = 0.001) and on the tenth day of onset (r = 0.532, p = 0.001). Individuals with severe-critical illness had lower ALC, CD4+, and CD8+ cell counts than those with mild-moderate illness. Conclusion: According to the findings of this study, there is a correlation between CD4+ and CD8+ cell counts and ALC in COVID-19 patients. All lymphocyte subsets also showed a lower value in severe forms of the disease.

1 March 2022 in Molecular and Cellular Biomedical Sciences
Verified
Journal Article
Open access
PDF file
PLPhey Liana
Phey Liana
KMKrisna Murti
Krisna Murti
ZHZen Hafy
Zen Hafy
ILIche Andriyani Liberty
Iche Andriyani Liberty
Tungki Pratama UmarTungki Pratama Umar
Tungki Pratama Umar
Neutrophil extracellular traps (NETs) are immune components found in a variety of pathological states. It has been shown to have either beneficial or harmful implications, depending on how it is controlled and has been particularly observed in three major scenarios: infection, autoimmune disease, and cancer. In this article, we compiled some of the roles of NETs in pathological conditions, as well as the benefits of targeting them for improved patient outcomes. The role of NETs were primarily positive in infectious disease, whether caused by bacteria, virus, or fungal infection. In non-infectious inflammatory scenarios, on the other hand, it's the complete opposite, with the effects being mainly deleterious and even worse than the original disease states. Targeting NETs directly or indirectly may help to prevent complications and improve patient outcomes. A plethora of compounds, including immunomodulators, anti-thrombosis, nicotinamide adenine dinucleotide phosphate (NADPH)/reactive oxygen species (ROS) inhibitors, nuclease, and other compounds, may be used to accomplish the therapeutic goals.

30 June 2023
Verified
Journal Article
Closed access
PLP Liana
P Liana
AJA Jenica
A Jenica
TST Suciati
T Suciati
ERE Rahmawati
E Rahmawati
PPP Pariyana
P Pariyana
TUT. P Umar
T. P Umar